SCHEMBL312875

SCHEMBL312875

CCOC(=O)Nc1cc(O)cnc1-c1cc(=O)c2ccccc2o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.58
HPGD P15428 5/20 0.58
HSD17B10 Q99714 2/20 0.58
LMNA P02545 2/20 0.58
TNKS O95271 5/20 0.50
MAOB P27338 1/20 0.47
CSNK2A2 P19784 1/20 0.47
CSNK2B P67870 1/20 0.47
CSNK2A1 P68400 1/20 0.47
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
BCHE P06276 1/20 0.43
POLB P06746 1/20 0.43
ACHE P22303 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311971 0.90 AKR1B1 (0.51) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311598 0.90 CSNK2A2 (0.46) KDM4EHPGDHSD17B10LMNAMAOB
SCHEMBL311513 0.87 AR (0.45) KDM4EHPGDHSD17B10LMNAMAOB
SCHEMBL312402 0.86 HPGD (0.43) KDM4EHPGDHSD17B10LMNAMAOB
SCHEMBL311138 0.84 HPGD (0.58) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL324201 0.82 HPGD (0.61) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312706 0.82 KDM4E (0.61) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL312009 0.82 KDM4E (0.58) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311129 0.79 HPGD (0.63) KDM4EHPGDHSD17B10LMNATNKS
SCHEMBL311720 0.79 HPGD (0.59) KDM4EHPGDHSD17B10LMNATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed